✦ LIBER ✦

Results of a pilot study of 40 patients using high-dose therapy with hematopoietic rescue after standard-dose adjuvant therapy for high-risk breast cancer

✍ Scribed by Tomás, J F; Pérez-Carrión, R; Escudero, A; López-Lorenzo, J L; López-Pascual, J; Fernández-Rañada, J M

Book ID: 110009996
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 75 KB
Volume: 19
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1700658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Year Results of Pulsed Dose Rate Brach

5-Year Results of Pulsed Dose Rate Brachytherapy Applied as a Boost after Breast-Conserving Therapy in Patients at High Risk for Local Recurrence from Breast Cancer

✍ Wolfgang Harms; Robert Krempien; Frank W. Hensley; Christiane Berns; Peter Fritz 📂 Article 📅 2002 🏛 Springer 🌐 German ⚖ 160 KB

Long-term assessment of cardiac function

Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer

✍ Maysa M. Abu-Khalaf; Vinni Juneja; Gina G. Chung; Michael P. DiGiovanna; Rebecca 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 209 KB

Adjuvant six cycles of high-dose adriamy

Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose acmf with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study

✍ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl

Feasibility of two dose-dense FEC regime

Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG)

✍ Zsuzsanna Kahán; Stanislav Spanik; Maria Wagnerova; Tomas Skacel; Barbara Planko 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 208 KB

Repetitive high-dose therapy with cyclop

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study

✍ Prince, H M; Rischin, D; Toner, G C; Seymour, J F; Blakey, D; Gates, P; Eerhard, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

Initial results of a phase II trial of h

Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group study

✍ James A. Martenson; Stuart R. Lipsitz; Henry Wagner Jr.; Edward H. Kaplan; Larry 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 606 KB